Jonathan Poyer21 hours ago2 minBiotech & HealthcareBiotech M&A Quiet Heading Into Earnings Season - Intra-Cellular (ITCI) Drug Hits in Clinical Trial and Creates Potential $1B+ Opportunity
Jonathan Poyer2 days ago1 minBiotech & HealthcareBiotech Capital Markets Activity - 130 Biotech Transactions YTD compared to Just 45 Last Year. $22B vs. $6B. Healthy Numbers but the Index Lags
Jonathan Poyer2 days ago2 minRobotics & AutomationThere is (Much) More to AI Markets than NVIDIA - And That Dip Might Mean a Good Time to Buy
Jonathan Poyer6 days ago1 minBiotech & HealthcareVertex Announces Their Largest Deal Ever While AbbVie's News Around Neuroscience Drug Maker Makes More Waves
Jonathan Poyer7 days ago2 minLifeSci Weekly UpdatesVertex Pharmaceuticals Announces Largest Acquisition Ever - But Biotech Index Dips
Jonathan PoyerApr 122 minMacro ViewsRisk On for Q1 - But Returns are Broadening Beyond Tech and Indices are at All-Time Highs
Jonathan PoyerApr 103 minBiotech & HealthcareBiotech Rise Starts to Come Down as Index Reverts to the Mean - But as Momentum Cools Solid Fundamentals Look Good
Jonathan PoyerApr 82 minBiotech & HealthcareBarrons Highlights a Potential Big Change in Bio Investing - What Happens When $100B in Revenue Comes Up for Grabs?
Jonathan PoyerApr 52 minReal EstateDiving Deep into the Waters of RMBS Investing. Should We Give Up on the Sector or Can It Become Attractive Again?
Jonathan PoyerApr 51 minBiotech & HealthcareMomentum and Story Stocks Narrowly Drive the Index - When Will Others Participate?
Jonathan PoyerApr 22 minLifeSci Weekly UpdatesMerck Hits All-Time High; But Momentum Trading Continues to Push Down the Biotech Index